A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/409 (2006.01) A61K 31/165 (2006.01) A61K 31/444 (2006.01) A61K 31/69 (2006.01) A61K 31/715 (2006.01) A61K 33/34 (2006.01) A61K 38/16 (2006.01) A61P 31/12 (2006.01)
Patent
CA 2623351
The field of the invention relates to the use of carbohydrate binding compounds as a medicine, their use to treat or prevent viral infections, their use to manufacture a medicine to treat or prevent viral infections and their use in a vaccination strategy. The present invention relates to the use of said compounds to manufacture a medicine to treat or prevent viral infections of subjects, more in particular infections with viruses having glycosilated envelop proteins such as Retroviridae (i.e. Lentivirinae), like HIV (human immunodeficiency virus), Flaviviridae, like HCV (hepatitis C virus), Hepadnaviridae, like HBV (hepatitis B virus), Coronaviridae, like SARS corona virus, and Orthomyxoviridae, like influenza A, B or C.
L'invention concerne l'utilisation de composés se liant à des sucres comme médicaments, leur utilisation pour traiter ou prévenir des infections virales, pour fabriquer un médicament destiné à traiter ou à prévenir des infections virales et à des fins de vaccination. L'invention concerne l'utilisation desdits composés pour fabriquer un médicament destiné à traiter ou à prévenir des infections virales chez des sujets, plus particulièrement des infections provoquées par des virus comportant des protéines d'enveloppe glycosylées telles que les Retroviridae (i.e. Lentivirinae) tels que le VIH (virus de l'immunodéficience humaine), les Flaviviridae tels que le VHC (virus de l'hépatite C), les Hepadnaviridae tels que le VHB (virus de l'hépatite B), les Coronaviridae tels que le coronavirus SARS, et les Orthomyxoviridae tels que le virus de la grippe A, B ou C.
Balzarini Jan
Mazik Monika
K.u.leuven Research And Development
Smart & Biggar
Technische Universitaet Carolo Wilhelmina Zu Braunschweig
LandOfFree
Antiviral therapy with carbohydrate binding agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral therapy with carbohydrate binding agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral therapy with carbohydrate binding agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1446437